Global Botulinum Toxin Market: Size, Trends and Forecasts (2018-2022 Edition)
- Report Description Table of Contents
Scope of the Report
The report titled “Global Botulinum Toxin Market: Size, Trends and Forecasts (2018-2022 Edition)” provides an in-depth analysis of the global botulinum toxin market with detailed analysis of the actual and the expected market size along with the market size of each market segment on the basis of application, products as well as regional.
The report provides detailed regional analysis of the US, Europe, Japan, Asia (excluding Japan),Korea and China for the botulinum toxin market. Regional analysis includes market share of each region or country and the actual and forecasted market size of the botulinum toxin market along with the market segments of the aforementioned regions.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global botulinum toxin market has also been forecasted for the period 2018-2022, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. The competition in the global botulinum toxin market is stiff and dominated by the big players like Allergan. Further, key players of the botulinum toxin market Ipsen and Revance are also profiled with their financial information and respective business strategies.
- The US
- Asia (excluding Japan)
- Allergan Plc.
- Revance Therapeutics, Inc.
Botulinum toxin is provided by a kind of bacteria called as clostridium botulinum, a gram-positive anaerobic bacterium. Botulinum toxin is fragmented into seven separate neurotoxins and used in therapeutic and aesthetic procedures. It is utilized as a part of relatively every sub-forte of pharmaceutical and for restorative reason for briefly lessening glabellar temple glare lines. The different botulinum toxins have singular potencies, and care is required to guarantee appropriate apply and avoid medication errors.
The global botulinum toxin market has increased at a significant annual growth rate in 2017 as compared to the preceding year 2016 and projections are made that the market would rise in the next five years i.e. 2018-2022 tremendously.
The upsurge in the market was due to various factors such as increased patient comfort, shorter procedure times and immediate results. The market can be segmented on the basis of application as therapeutics and cosmetic/aesthetic, of which therapeutics govern the market.
The major growth drivers for the botulinum toxin market are: ageing population, escalating numbers of surgeons, upsurge in facial aesthetics procedures, rising alternative of non-surgical procedures, increasing healthcare spending in emerging markets. Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as potential health risk associated with botulinum toxin and botulinum toxins as bio-terror threat.
Rise in medical tourism, reduced safety concerns and simple and instant characteristic and scope of botulinum toxin in treatment of Necrotizing Fasciitis are some of the latest trends existing in the market.